Orthofix Medical (OFIX) Price to Earnings Ratio

Corporate emblem and logo of Orthofix Medical (OFIX)

The Orthofix Medical Inc. (OFIX) spinal implant ecosystem ensures absolute B2B customer loyalty, which is reflected in the company's forward P/E, where the current mark is -6.50. A specialization in spinal reconstruction guarantees order stability. Strong pricing power is supported by inelastic demand for innovative biomaterials that accelerate tissue regeneration following severe injuries.

Orthofix Corp (OFIX) Price to Earnings Ratio: for the period 07/04/2022 - 11/11/2026

Comprehensive metric breakdowns and analytics for Orthofix International (OFIX)

- price and consensus price forecast:
Stock Price orthofix.com|OFIX - Price Target Chart
- market capitalization details:
Market Value Orthofix Medical|OFIX - Enterprise Value
- book capitalization information:
Net Assets per Share Orthofix|OFIX - Company Net Assets|Market Capitalization to Net Assets orthofix.com|OFIX - Company Total Assets
- debt and solvency information:
Debt to Capital Orthofix Medical Inc.|OFIX - Long-Term Debt to Capital|Short-Term Debt to Capital Ratio Orthofix Corp|OFIX - Company Total Debt|Debt to Net Assets Ratio Orthofix Medical|OFIX - Company Long-Term Debt|Company Current Liabilities Orthofix|Immediate Liquidity orthofix.com
- earnings and market multiples details:
OFIX - Net Profit|Net Profit Forecast Orthofix Medical Inc.|OFIX - P/E Multiple|Market Cap to Projected Earnings Orthofix Medical|OFIX - PEG Multiple|Enterprise Value to EBITDA Ratio Orthofix Medical|OFIX - Operating profit EBITDA|Net earnings per share (EPS TTM) Orthofix|OFIX - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months orthofix.com|OFIX - Net earnings per share growth this year|Expected earnings per share trend next year Orthofix Medical Inc.
General company analysis:orthofix.com - OFIX
Original product of orthofix.com

The reputational capital of Orthofix Medical Inc. (OFIX) in the field of high-tech spinal surgery creates a market premium that investors are willing to pay for implant reliability. The ratio of market capitalization to net income, displayed via the company's forward P/E on GURU.Markets, measures this premium, allowing for an assessment of the business valuation relative to its actual earnings and helping to avoid the risks of purchasing an asset at the peak of unjustified optimism.

Analysis of competing companies

P/E Multiple bostonscientific.com|Price to Earnings Ratio Edwards Lifesciences Corporation (EW)|Price to Earnings Ratio RMD (ResMed Inc)|P/E Multiple PODD (OmniPod)|Business Payback Period Zimmer Biomet (ZBH)|COO: Price to Earnings Ratio|Market Cap to Net Income ALGN|GMED: P/E Multiple|Market Cap to Earnings TransMedics Organ Care System (TMDX)|ATEC (ATEC Spine) - P/E Multiple|Price to Earnings Multiple AORT (Artivion Corp)|Price to Earnings Ratio ENOV (Enovis Corporation)|IART (integralife.com) - Company Value to Net Income|Price to Earnings Ratio Establishment Labs Holdings Inc. ESTA|BBNX - Price to Earnings Ratio|Iradimed - P/E Multiple|Market Cap to Earnings Embecta Health|TNDM: P/E Multiple|Price to Earnings Multiple AXGN|SIBN (SI-BONE) - P/E Multiple|Bioventus Inc (BVS) - Business Payback Period|P/E Multiple KIDS|Price to Earnings Ratio Treace Corp TMCI|P/E Multiple SRTA (Strata Critical Medical Inc)|P/E Multiple carlsmed.com CARL|RXST - Price to Earnings Ratio|CLPT: Price to Earnings Ratio|STXS (Stereotaxis Corp) - Price to Earnings Ratio|Neuronetics, Inc - Company Value to Net Income|SGHT (Sight Sciences, Inc.) - P/E Multiple|Market Cap to Earnings orchestrabiomed.com OBIO|Price to Earnings Ratio Anika Therapeutics (ANIK)|InspireMD Inc (NSPR) - Market Cap to Net Income Ratio|Jin Medical - Price to Earnings Ratio|P/E Multiple Vivani Medical Inc VANI|Xtant Medical Inc - P/E Multiple|Business Payback Period n1mtc.com NMTC|modular-medical.com (MODD) - Price to Earnings Ratio|Market Cap to Net Income MYO (Myomo Inc.)|Price to Earnings Ratio Envoy Medical, Inc|Price to Earnings Ratio Vivos Therapeutics Inc (VVOS)|P/E Multiple NVNO|SINT - Market Cap to Earnings|Price to Earnings Ratio Tenon Medical TNON|LFWD: Price to Earnings Multiple|AMIX: Price to Earnings Ratio|INVO Fertility Corp - Market Price to Net Income Ratio|Bone Biologics (BBLG) - Price to Earnings Ratio|Market Cap to Earnings axonics.com (AXNX)|Price to Earnings Ratio BIOLASE|DYNT: Company Value to Net Income|Price to Earnings Ratio FNA (Paragon 28, Inc.)|Market Price to Net Income Ratio INVO